Disease/Condition
377 Clinical Trials
10+ Countries
Chronic Hepatitis B Clinical Trials Database - Free Access to 377 Studies
Access comprehensive clinical trial information for Chronic Hepatitis B through Pure Global AI's free database. This collection includes 377 clinical trials across multiple phases including N/A, Phase 4, Phase 2. Currently, 55 trials are actively recruiting participants.
Research for Chronic Hepatitis B is being conducted in China, South Korea, United States of America and 7+ other countries. Leading sponsors include Gilead Sciences and Assembly Biosciences. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
N/A
110Phase 4
92Phase 2
64Phase 1
52Phase 3
34By Status
Completed
184Unknown
70Recruiting
55Not yet recruit...
30Terminated
18Top Countries
China130
South Korea39
United States of America21
Taiwan12
New Zealand9
Top Sponsors
Gilead Sciences30
Assembly Bioscienc...19
Beijing Ditan Hosp...17
Bristol-Myers Squi...12
Gilead Sciences, I...10
Recent Trials
Latest clinical trials for Chronic Hepatitis B
2016-000785-37
A study to understand the safety and effectiveness of a new drug called TAF for the treatment of long term hepatitis B infection in adolescents
Gilead Sciences, Inc.
2019-003269-16
A study to understand the rate at which the oral granules of the TAF drug are absorbed in healthy adults
Gilead Sciences, Inc.
NCT06384131
Phase 1
Not yet recr...
A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection
Assembly Biosciences
NCT06364930
Phase 4
Recruiting
SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
Chinese University of Hong Kon...China
NCT06357806
Recruiting
The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients
Beijing 302 HospitalChina
NCT06313255
Recruiting
A Retrospective Observational Study on the Effects of Probiotics on HBsAg Clearance
Qilu Hospital of Shandong Univ...China
NCT06311734
Phase 1
Recruitment ...
A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection
Shanghai Longwood Biopharmaceu...China
NCT06221605
Not yet recr...
Regulation of Intestinal Flora by Compound Probiotics in Patients With Chronic Hepatitis B
Wecare Probiotics Co., Ltd.
NCT06263959
Phase 2
Recruiting
A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
Fujian Akeylink Biotechnology ...China
NCT06154278
Phase 2
Not yet recr...
Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B
University of Maryland, Baltim...
NCT06092333
Phase 2
Not yet recr...
VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
National Institute of Diabetes...United States of America
NCT06070051
Phase 1
Recruiting
Dose-Escalation Prime/Boost Therapeutic Vaccination Study Of 2 Chimp Adenoviral Vectors in Adults With Chronic HBV On Nucleos(t)Ide Therapy
Virion TherapeuticsChina,New Zealand
ANZCTR12623000997651
Phase 1
Not yet recr...
A Phase 1, Placebo-controlled, First-in-human Study of Orally Administered DF-006 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Multiple Doses in Chronic Hepatitis B subjects
Zhejiang Yao Yuan Biotechnolog...New Zealand;China;China;South Korea
ANZCTR12623000841673
Phase 1
Recruiting
Study to Evaluate the Safety, Tolerability, Immunogenicity and Antiviral Activity of Multiple Doses of CLB-3000 in participants with Chronic Hepatitis B
ClearB Therapeutics, Inc.Australia
NCT05905458
Phase 2
Not yet recr...
A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)
Chengdu Suncadia Medicine Co.,...
NCT05905731
Phase 1
Not yet recr...
Autologous T-cells Transfected With mRNA Encoding HBV-TCR T Cell Therapy in Combination With NUC for Chronic Hepatitis B
Beijing 302 HospitalChina
NCT05839639
Phase 2
Not yet recr...
A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Reverse Transcriptase Inhibitors
Huahui HealthChina
NCT05808374
Phase 1
Recruiting
Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetic Characteristics of Single Administration of HRS-5635 Injection in Chinese Healthy Subjects and the Safety, Tolerance, Pharmacokinetics and Antiviral Effect of Multiple Administration in Patients With Chronic Hepatitis B
Fujian Shengdi Pharmaceutical ...China
NCT05808335
Phase 2
Recruiting
A Study to Assess the Efficacy and Safety of Burfiralimab(hzVSF-v13) and OAD (Oral Antiviral Drug)
ImmuneMed, Inc.South Korea
NCT05770895
Phase 1
Recruiting
Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B
Gilead SciencesNew Zealand
About Chronic Hepatitis B Research
Pure Global AI provides free access to 377 clinical trials studying Chronic Hepatitis B, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Gilead Sciences, Assembly Biosciences, Beijing Ditan Hospital, among others.
Quick Facts
Total Trials377
Countries10+
Sponsors10+
Recruiting55